ℹ️ Skipped - page is already crawled
| Filter | Status | Condition | Details |
|---|---|---|---|
| HTTP status | PASS | download_http_code = 200 | HTTP 200 |
| Age cutoff | PASS | download_stamp > now() - 6 MONTH | 2.4 months ago |
| History drop | PASS | isNull(history_drop_reason) | No drop reason |
| Spam/ban | PASS | fh_dont_index != 1 AND ml_spam_score = 0 | ml_spam_score=0 |
| Canonical | PASS | meta_canonical IS NULL OR = '' OR = src_unparsed | Not set |
| Property | Value |
|---|---|
| URL | https://www.axios.com/2021/09/26/pfizer-children-covid-vaccine |
| Last Crawled | 2026-02-02 10:00:29 (2 months ago) |
| First Indexed | 2022-05-07 00:37:31 (3 years ago) |
| HTTP Status Code | 200 |
| Meta Title | Pfizer CEO: Company will submit data for children's vaccine to FDA in "days" |
| Meta Description | Pfizer earlier this week announced trials indicate its vaccine is safe and effective for children ages 5 to 11. |
| Meta Canonical | null |
| Boilerpipe Text | Ivana Saric
Pfizer CEO Albert Bourla. Photo: John Thys/POOL/AFP via Getty Images
Pfizer plans to submit data about its COVID-19 vaccine for children ages 5 to 11 to the Food and Drug Administration "pretty soon," CEO Albert Bourla told ABC's "
This Week
" on Sunday.
Why it matters:
The start of the school year saw a rise in COVID-19
infections among kids
, and heightened the focus on when the vaccine will be available for children.
Earlier this week, Pfizer announced that results from its pediatric trial indicate that its vaccine — in a smaller dosage than given to adults — is
safe and effective for children
ages 5 to 11.
What he's saying:
"I think we're going to submit this data pretty soon. It's a question of days, not weeks," Bourla said.
"Then it is up to the FDA to be able to review the data and come to their conclusions, and approve it or not."
"If they approve it, we will be ready with our manufacturing to provide this new formulation of the vaccine," Bourla said.
Go deeper:
Pfizer coronavirus vaccine safe, effective in children, company says |
| Markdown | [Skip to main content](https://www.axios.com/2021/09/26/pfizer-children-covid-vaccine#main-content)
- [Newsletters](https://www.axios.com/newsletters)
- Axios Local
Show
- [Axios Pro](https://www.axios.com/pro/all-deals)
- [Axios Live](https://www.axios.com/events)
- [The Axios Show](https://www.axios.com/the-axios-show)
Login
[Axios](https://www.axios.com/)
All topics
[Axios](https://www.axios.com/)
Search
Sep 26, 2021 - [Health](https://www.axios.com/health)
# Pfizer CEO: Company will submit data for children's vaccine to FDA in "days"

- [Ivana Saric](https://www.axios.com/authors/isaric)
- facebook (opens in new window)
- twitter (opens in new window)
- linkedin (opens in new window)
- email (opens in new window)
- sms (opens in new window)
[Add Axios on Google](https://google.com/preferences/source?q=axios.com)
Add Axios as your preferred source to
see more of our stories on Google.
[Add Axios on Google](https://google.com/preferences/source?q=axios.com)

Pfizer CEO Albert Bourla. Photo: John Thys/POOL/AFP via Getty Images
Pfizer plans to submit data about its COVID-19 vaccine for children ages 5 to 11 to the Food and Drug Administration "pretty soon," CEO Albert Bourla told ABC's "[This Week](https://twitter.com/ThisWeekABC/status/1442132591855951873)" on Sunday.
**Why it matters:** The start of the school year saw a rise in COVID-19 [infections among kids](https://www.axios.com/children-health-covid-cases-school-c985ccf6-b927-4b9f-b787-16b27e644e9f.html), and heightened the focus on when the vaccine will be available for children.
- Earlier this week, Pfizer announced that results from its pediatric trial indicate that its vaccine — in a smaller dosage than given to adults — is [safe and effective for children](https://www.axios.com/pfizer-vaccine-children-results-safe-effective-c0343dd6-b86a-4cb6-ab1b-ad5f973e68cc.html) ages 5 to 11.
**What he's saying:** "I think we're going to submit this data pretty soon. It's a question of days, not weeks," Bourla said.
- "Then it is up to the FDA to be able to review the data and come to their conclusions, and approve it or not."
- "If they approve it, we will be ready with our manufacturing to provide this new formulation of the vaccine," Bourla said.
**Go deeper:** [Pfizer coronavirus vaccine safe, effective in children, company says](https://www.axios.com/pfizer-vaccine-children-results-safe-effective-c0343dd6-b86a-4cb6-ab1b-ad5f973e68cc.html)
- facebook (opens in new window)
- twitter (opens in new window)
- linkedin (opens in new window)
- email (opens in new window)
- sms (opens in new window)
[Add Axios on Google](https://google.com/preferences/source?q=axios.com)
##### What to read next
- 
- 
- 
- 
- 
Smarter, faster on what matters.
[Explore Axios Newsletters](https://www.axios.com/newsletters)
- [About Axios](https://www.axios.com/about)
- [Advertise with us](https://www.axios.com/advertise)
- [Careers](https://www.axios.com/careers)
- [Contact us](https://www.axios.com/contact)
- [Newsletters](https://www.axios.com/newsletters)
- [Axios Live](https://www.axios.com/events)
- [Axios HQ](https://www.axioshq.com/?utm_source=axios&utm_medium=site&utm_campaign=axioshq)
- [Privacy policy](https://www.axios.com/legal)
- [Terms of use](https://www.axios.com/legal/terms-of-use)
[Axios Homepage](https://www.axios.com/)
Axios Media Inc., 2026 |
| Readable Markdown | 
- [Ivana Saric](https://www.axios.com/authors/isaric)

Pfizer CEO Albert Bourla. Photo: John Thys/POOL/AFP via Getty Images
Pfizer plans to submit data about its COVID-19 vaccine for children ages 5 to 11 to the Food and Drug Administration "pretty soon," CEO Albert Bourla told ABC's "[This Week](https://twitter.com/ThisWeekABC/status/1442132591855951873)" on Sunday. **Why it matters:** The start of the school year saw a rise in COVID-19 [infections among kids](https://www.axios.com/children-health-covid-cases-school-c985ccf6-b927-4b9f-b787-16b27e644e9f.html), and heightened the focus on when the vaccine will be available for children.
Earlier this week, Pfizer announced that results from its pediatric trial indicate that its vaccine — in a smaller dosage than given to adults — is [safe and effective for children](https://www.axios.com/pfizer-vaccine-children-results-safe-effective-c0343dd6-b86a-4cb6-ab1b-ad5f973e68cc.html) ages 5 to 11. **What he's saying:** "I think we're going to submit this data pretty soon. It's a question of days, not weeks," Bourla said. "Then it is up to the FDA to be able to review the data and come to their conclusions, and approve it or not." "If they approve it, we will be ready with our manufacturing to provide this new formulation of the vaccine," Bourla said. **Go deeper:** [Pfizer coronavirus vaccine safe, effective in children, company says](https://www.axios.com/pfizer-vaccine-children-results-safe-effective-c0343dd6-b86a-4cb6-ab1b-ad5f973e68cc.html) |
| Shard | 115 (laksa) |
| Root Hash | 8292587546678785315 |
| Unparsed URL | com,axios!www,/2021/09/26/pfizer-children-covid-vaccine s443 |